Open access · CC-BY
via OpenAlex
Cytokine interplay among the diseased retina, inflammatory cells and mesenchymal stem cells - a clue to stem cell-based therapy
Vladimír Holáň, Barbora Heřmánková, Magdaléna Krulová, Alena Zajícová
World Journal of Stem Cells · 2019 · ▲ 40 citations
Abstract
Retinal degenerative disorders, such as diabetic retinopathy, retinitis pigmentosa, age-related macular degeneration or glaucoma, represent the most common causes of loss of vision and blindness. In spite of intensive research, treatment options to prevent, stop or cure these diseases are limited. Newer therapeutic approaches are offered by stem cell-based therapy. To date, various types of stem cells have been evaluated in a range of models. Among them, mesenchymal stem/stromal cells (MSCs) derived from bone marrow or adipose tissue and used as autologous cells have been proposed to have the potential to attenuate the negative manifestations of retinal diseases. MSCs delivered to the vicinity of the diseased retina can exert local anti-inflammatory and repair-promoting/regenerative effects on retinal cells. However, MSCs also produce numerous factors that could have negative impacts on retinal regeneration. The secretory activity of MSCs is strongly influenced by the cytokine environment. Therefore, the interactions among the molecules produced by the diseased retina, cytokines secreted by inflammatory cells and factors produced by MSCs will decide the development and propagation of retinal diseases. Here we discuss the interactions among cytokines and other factors in the environment of the diseased retina treated by MSCs, and we present results supporting immunoregulatory and trophic roles of molecules secreted in the vicinity of the retina during MSC-based therapy.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.4252/wjsc.v11.i11.957
- Canonical
- link ↗
- Fetched
- 2026-11-14 MST
Cite this
APA
Holáň, V., Heřmánková, B., Krulová, M., & Zajícová, A. (2019). Cytokine interplay among the diseased retina, inflammatory cells and mesenchymal stem cells - a clue to stem cell-based therapy. <em>World Journal of Stem Cells</em>. https://doi.org/10.4252/wjsc.v11.i11.957
Vancouver
Holáň V, Heřmánková B, Krulová M, Zajícová A. Cytokine interplay among the diseased retina, inflammatory cells and mesenchymal stem cells - a clue to stem cell-based therapy. World Journal of Stem Cells. 2019. doi:10.4252/wjsc.v11.i11.957.
BibTeX
@article{vladimr2019Cytoki,
title = {Cytokine interplay among the diseased retina, inflammatory cells and mesenchymal stem cells - a clue to stem cell-based therapy},
author = {Vladimír Holáň and Barbora Heřmánková and Magdaléna Krulová and Alena Zajícová},
journal = {World Journal of Stem Cells},
year = {2019},
doi = {10.4252/wjsc.v11.i11.957},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cells 2021
Open access · CC-BY
Mesenchymal Stem Cell-Based Therapy for Retinal Degenerative Diseases: Experimental Models and Clinical Trials
Signal Transduction and Targeted Therapy 2025
Open access · CC-BY
Mesenchymal stem cells in treating human diseases: molecular mechanisms and clinical studies
BioResearch open access 2015
Open access · OA
Autologous Stem Cell Therapy: How Aging and Chronic Diseases Affect Stem and Progenitor Cells
International Journal of Molecular Sciences 2021
Open access · CC-BY
Mesenchymal Stem Cells Therapies on Fibrotic Heart Diseases
Journal of Cellular Physiology 2009
Preprint · OA
Mesenchymal stem cells in regenerative medicine: Opportunities and challenges for articular cartilage and intervertebral disc tissue engineering
Journal of Cellular Immunotherapy 2015
Open access · CC-BY